Q
Quant'AbondanceL'abondance, quantifiée.

Actualités

Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

25,247 signal articles · 242 in last 24h · 120,481 total before filter · latest 36m ago
242last 24h
1395last 7d
239● bullish (7d)
152● bearish (7d)
205publishers
AllMacro251Earnings523M&A102Regulatory18Product9Analyst20
✕ clear all filterssentiment: bullishSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Raised 2026 Outlook and Backlog Surge Could Be A Game Changer For Quanta Services (PWR)
Simply Wall St.20d agobullish
Raised 2026 Outlook and Backlog Surge Could Be A Game Changer For Quanta Services (PWR)

In late July 2026, Quanta Services, Inc. reported second-quarter results showing revenue of US$9.56 billion and net income of US$451.38 million, alongside higher full-year 2026 guidance calling for US$39.30–US$39.70 billion in revenue and US$1.74–US$1.82 billion in net income, with diluted EPS projected at US$11.41–US$11.92. Management cited strong demand in its electric infrastructure business, a record backlog, and the contribution of four recent acquisitions as key reasons for the...

AbbVie’s (NYSE:ABBV) Q2 CY2026: Beats On Revenue
StockStory20d agobullish
AbbVie’s (NYSE:ABBV) Q2 CY2026: Beats On Revenue

Pharmaceutical company AbbVie (NYSE:ABBV) beat Wall Street’s revenue expectations in Q2 CY2026, with sales up 10.2% year on year to $16.99 billion. Its non-GAAP profit of $3.65 per share was 1.2% above analysts’ consensus estimates.

This Week In Cloud AI - AI Spending Soars Worldwide As Industries Transform
Simply Wall St.20d agobullish
This Week In Cloud AI - AI Spending Soars Worldwide As Industries Transform

In its first year, BCC Research's Artificial Intelligence vertical has developed a comprehensive suite of reports to provide a detailed view of the global AI market. This collection includes quarterly Core Four reports alongside monthly Pulse Reports and an AI Sentiment Index, offering insights into AI adoption, disruption, usage, and investment across various industries worldwide. Notably, the reports highlight a structural shift in industries such as finance, logistics, and digital health,...

2 ‘Strong Buy’ IPO Stocks JPMorgan Thinks Are Worth Watching
TipRanks20d agobullish
2 ‘Strong Buy’ IPO Stocks JPMorgan Thinks Are Worth Watching

The IPO market has made an impressive comeback this year. Momentum began building in the first quarter and accelerated in the second, with traditional IPOs raising $114.1 billion through June 30, 2026 – roughly seven times the amount raised during the first half of 2025. SpaceX, the largest IPO in Wall Street history, understandably dominated the headlines and made Elon Musk the world’s first trillionaire, but the strength of the market extended well beyond a single blockbuster listing.Claim 55%

AbbVie Bought Apogee to Strengthen Its Portfolio. Now It’s Cutting Earnings Guidance.
Barrons.com20d agobullish
AbbVie Bought Apogee to Strengthen Its Portfolio. Now It’s Cutting Earnings Guidance.

AbbVie shares took a hit Friday after costs related to the drugmaker’s acquisition of Apogee Therapeutics forced a cut to its full-year profit outlook. Second-quarter revenue jumped 10% to nearly $17 billion, beating the $16.8 billion consensus estimate among analysts polled by FactSet. AbbVie posted adjusted earnings of $3.65 a share, narrowly ahead of Wall Street’s call for $3.60.